Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?

To: Jenna who wrote (103225)	6/20/2000 9:39:00 PM
From: Sosmartinov	Respond to of 120523

WIND...AH prints almost 44, if it holds close to that it breaks a double top on P&F....charts look good, news is good, and moved today on a so-so mrkt.

To: Jenna who wrote (103225)	6/20/2000 10:25:00 PM
From: Jenna	Read Replies (1) \| Respond to of 120523

Tomorrow: MKTY, XLA.. also ENE

To: Jenna who wrote (103225)	6/20/2000 11:14:00 PM
From: kha vu	Respond to of 120523

In this watchlist, AKAM and AVNX are the TWO that give $3 each for today scalping. CBMI seems to be a good find with nice move: <<<Creative BioMolecules, Inc. is a biopharmaceutical company focused on the development of products for human tissue regeneration and repair. Its core technologies are based on understanding the role that morphogenic proteins play in human biology. These proteins are involved in the initiation and regulation of the cellular events responsible for the formation of human tissues and organs. Its goal is to apply certain aspects of genetic engineering and its understanding of cellular biology to the development and commercialization of morphogenic proteins and related compounds to treat a wide array of medical conditions. The Company has product candidates in development for several applications including orthopedic and dental reconstruction, treatment of kidney disease, and treatment of stroke and other neurological disorders. On February 15, 2000, the Company announced that it will merge with Ontogeny, Inc., and Reprogenesis, Inc., to form a public company named Curis, Incorporated.>>> Insider: 29% ú Institutional: 36% (50% of float) (63 institutions) ú Net Inst. Buying: 4.79M shares (+26.04%) biz.yahoo.com